Rockefeller Financial Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$28K Hold
253
﹤0.01% 451
2017
Q3
$27K Buy
+253
New +$26K ﹤0.01% 458

Other funds holding CRL

Rockefeller Financial Services's CRL Position: Q4 2017 in Review

Rockefeller Financial Services held its Charles River Laboratories (CRL) position steady in Q4 2017 at 253 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Rockefeller Financial Services first reported a position in CRL in Q3 2017 and has held it in 2 quarters since. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

  • Rockefeller Financial Services held 253 shares of Charles River Laboratories worth $28K as of Q4 2017.
  • Rockefeller Financial Services left its Charles River Laboratories share count unchanged in Q4 2017.
  • Charles River Laboratories made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #451 holding.
  • Rockefeller Financial Services first reported a position in Charles River Laboratories in Q3 2017 and has held it in 2 quarters since.
  • 339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.